HIV Chemoprophylaxis for Adolescents: Educable Moment, Not Magic BulletMAYER, Kenneth H; ZANONI, Brian C.Clinical infectious diseases. 2013, Vol 56, Num 8, pp 1156-1158, issn 1058-4838, 3 p.Article

Pyrazolecarboxamide human neuropeptide Y5 receptor ligands with in vivo antifeedant activityKORDIK, Cheryl P; CHI LUO; ZANONI, Brian C et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 17, pp 2287-2290, issn 0960-894XArticle

Aminopyrazoles with high affinity for the human neuropeptide Y5 receptorKORDIK, Cheryl P; CHI LUO; ZANONI, Brian C et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 17, pp 2283-2286, issn 0960-894XArticle

Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAARTZANONI, Brian C; PHUNGULA, Thuli; ZANONI, Holly M et al.AIDS (London). 2011, Vol 25, Num 1, pp 49-55, issn 0269-9370, 7 p.Article

Sex Differences in HIV RNA Level and CD4 Cell Percentage During ChildhoodRUEL, Theodore D; ZANONI, Brian C; SSEWANYANA, Isaac et al.Clinical infectious diseases. 2011, Vol 53, Num 6, pp 592-599, issn 1058-4838, 8 p.Article